Annalise Di Marco
Experimental Pharmacology Unit. IRBM S.p.A, Pomezia
Rome, 00071, Italy
Rome, 00071, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Discovery and Optimization of IRBM-Z-2, an Allosteric Zika Virus NS2B-NS3 Protease Inhibitor Exhibiting In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: May 29, 2026
Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers.
Journal: Journal of medicinal chemistry
Published: April 13, 2026
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases.
Journal: Journal of medicinal chemistry
Published: January 31, 2025
Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors.
Journal: ACS medicinal chemistry letters
Published: October 21, 2022
Modelling the Human Blood-Brain Barrier in Huntington Disease.
Journal: International journal of molecular sciences
Published: May 25, 2022
Transport of cationic liposomes in a human blood brain barrier model: Role of the stereochemistry of the gemini amphiphile on liposome biological features.
Journal: Journal of colloid and interface science
Published: February 11, 2022
Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration.
Journal: Journal of medicinal chemistry
Published: December 15, 2020
Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System.
Journal: Cells
Published: March 12, 2020
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.
Journal: ACS medicinal chemistry letters
Published: December 16, 2019
Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Journal: Molecular pharmaceutics
Published: March 28, 2019
Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
Journal: Pharmaceutics
Published: February 26, 2019
Last Updated: 09/26/2026